Inspired by Jegadeesh and Titman: Cross-Sectional Momentum
TRADE-OFFStocks that outperformed over the past 3-12 months keep outperforming over the next 3-12 months.
How this run differs from the source: Drops stocks up more than 150%, a cap the paper does not have, and holds 20 names for one month, not deciles for 3 to 12 months.
| THE STRATEGY | $SPXTR BUY & HOLD | |
|---|---|---|
| CAGR | 16.3% | 9.3% |
| Sharpe ratio | 0.66 | 0.66 |
| Max drawdown | -66.5% | -50.9% |
// GROWTH OF $1, LOG SCALE
Out-of-sample (from the split): CAGR 15.9% against 14.0% for the benchmark; Sharpe 0.65 in-sample, 0.67 out-of-sample.
After 25 bps of trading costs: 10.6% a year. EDGE OVER RANDOM
// DECADE BY DECADE
| ERA | STRATEGY | BENCHMARK |
|---|---|---|
| 1990s | 64.4% | 20.9% |
| 2000s | 3.0% | -0.8% |
| 2010s | 18.5% | 14.0% |
| 2020s | 22.0% | 15.2% |
// YEAR BY YEAR, LOSING YEARS IN RED
Losing years: 2000 (-20.5%), 2002 (-10.7%), 2008 (-46.8%), 2009 (-9.0%), 2018 (-16.7%), 2022 (-1.5%). Each cell: the strategy, then the benchmark below it. * a part year.
// THE IDEA, AS PUBLISHED
Jegadeesh & Titman (1993), Journal of Finance · 1993
- Rank NYSE and AMEX stocks on their past 3, 6, 9 or 12-month return (no gap, or a one-week gap)
- Buy the top decile, sell the bottom decile, equal-weighted
- Form monthly and hold 3 to 12 months in overlapping cohorts
A real computation on the QuantGPT warehouse, walk-forward. A study across the whole market includes only part of the companies that later delisted from 1998 (survivors only before); a study on your own list of tickers is not affected. Gross returns, no costs except where stated. Past performance is not a promise. Findings, not advice. COMPUTED 2026-11-08 20:46 ON THE QUANTGPT WAREHOUSE. COMPANIES THAT LATER DELISTED ARE ONLY PARTLY IN THIS UNIVERSE (A FIX IS IN PROGRESS), SO THE RESULT LEANS TOWARD SURVIVORS. FUNDAMENTALS BY FILING DATE. NOT INVESTMENT ADVICE. PRIVACY